Showing results (691-700 of 8,885) with videos related to

Sort By:
Pageof 889
European Urology|January 1, 1995
Effects of the nonsteroidal antiandrogen Casodex on lipoproteins, fibrinogen and plasminogen activator inhibitor in patients with benign prostatic hyperplasiaL M Eri, P Urdal
European Urology|January 1, 1995
Effect of ejaculation on prostate-specific antigen levels in normal menZ Kirkali, G Kirkali, A Esen
European Urology|January 1, 1995
Late effects of intravesical bacillus Calmette-Guérin immunotherapy on bladder mucosa infiltrating lymphocytes: an immunohistochemical studyC Boccafoschi, F Montefiore, M Pavesi, et al.
European Urology|January 1, 1994
Relationship of ultrasonographic findings to histology in prostate cancerY Hasegawa, N Sakamoto
European Urology|January 1, 1994
Reduction of serum prostate-specific antigen during endocrine or cytotoxic treatment of hormone-resistant cancer of the prostate. A preliminary reportS D Fosså, E Paus
European Urology|January 1, 1994
Strontium-89 (Metastron) in the treatment of prostate cancer metastatic to boneA T Porter
European Urology|January 1, 1995
Multicenter observational trial on symptomatic treatment of benign prostatic hyperplasia with alfuzosin: clinical evaluation of impact on patient's quality of life. The Italian Alfuzosin Cooperative Group
European Urology|January 1, 1995
Potential effects of age-specific reference ranges for serum prostate-specific antigenS P Lankford, K L Peters, R C Elser
European Urology|January 1, 1997
New perspectives in the treatment of prostate cancerJ A Schalken
European Urology|January 1, 1997
Comparison of patients' assessment of urinary flow strength with uroflowmetryD R Small, D J Lanigan, A B Khan, et al.
Pageof 889